Navigation Links
Schering-Plough Reports Financial Results for Third Quarter of 2008
Date:10/21/2008

now "particularly well positioned" for the following reasons:

-- Broad diversification in geographic markets and businesses, with the

consumer and animal health segments together generating about 23 percent

of GAAP net sales;

-- Relatively long period of expected market exclusivity for key

prescription products, affording protection well into the next decade;

-- Robust research pipeline, with 10 projects in Phase III;

-- Near-term opportunities, including the biologic golimumab, filed in the

EU; sugammadex, now being launched as BRIDION in EU countries; and

asenapine, under U.S. regulatory review; and

-- Sound financial management, with rigorous cost controls in place to

reduce costs and improve efficiencies and productivity.

The Productivity Transformation Program (PTP), announced in April 2008, is expected to realize savings of $1.5 billion by the end of 2012, with $1.25 billion in savings targeted to be accomplished by 2010. The $1.5 billion target includes $500 million of previously announced integration synergy targets from the OBS acquisition. The company is making steady progress toward achieving these savings targets.

Third Quarter 2008 Results

For the 2008 third quarter, Schering-Plough reported net income available to common shareholders of $551 million or 34 cents per common share on a GAAP basis. Earnings per common share for the 2008 third quarter would have been 39 cents on net income of $639 million on a reconciled basis, which excludes purchase accounting adjustments, special and acquisition-related items, a $160 million pre-tax gain from the previously announced divestitures of certain animal health products and $19 million of income from the termination of a respiratory joint venture with Merck. For the 2007 third quarter, Schering-Plough reported net income available to common shareholders of $713 million or 45 cents per comm
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine news :

1. Schering-Plough Announces Transition of Animal Health Leadership
2. Schering-Plough and Merck Announce Withdrawal of Loratadine/Montelukast NDA and Termination of Respiratory Joint Venture
3. Hagens Berman Appointed Co-Lead Counsel in Case Against Schering-Plough and Merck
4. Emerging Combination Therapies, Including Drugs from Novartis/Schering-Plough and GlaxoSmithKline/Theravance Will Drive the COPD Drug Market to More Than $11 Billion in 2017
5. Bayer/Schering-Plough/Shionogis Avelox Has Advantages Over Levofloxacin in the Treatment of Community-Acquired Pneumonia
6. Schering-Plough Announces Expanded Stock Retention Guidelines for Senior Management
7. Schering-Plough to Webcast Presentation by CEO Fred Hassan at Lehman Brothers Eleventh Annual Global Healthcare Conference
8. Schering-Plough Promotes Ian Mcinnes to President of Global Supply Chain
9. CORRECTED: Hagens Berman Sobol Shapiro Files Suit Against Merck and Schering-Plough
10. Lawsuit Filed in Florida Federal Court Over Marketing of Vytorin and Zetia By Merck and Schering-Plough
11. Schering-Plough CEO to Buy $2 Million in Common Shares
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/18/2014)... CA (PRWEB) November 18, 2014 As ... new routines, many people look at fall as the ... Dr. Kevin Sadati , Orange County facial plastic ... Newport Beach practice. At the Gallery of Cosmetic ... taking advantage of his non-invasive cosmetic surgery procedures. ...
(Date:11/18/2014)... Haelle HealthDay Reporter MONDAY, ... experience a severe abusive head trauma before the age of ... new study. In addition, among those who survive ... the study found. Abusive head trauma includes shaken baby ... suffers head injuries, according to background information in the study. ...
(Date:11/18/2014)... Dennis Thompson ... News) -- Daily low-dose aspirin therapy may not have ... The study, which involved more than 14,000 ... difference in heart-related deaths or non-fatal heart attacks and ... didn,t. "It indicates that primary prevention with ...
(Date:11/18/2014)... HealthDay Reporter , MONDAY, Nov. ... can safely take aspirin combined with a blood-thinning medication, new ... patient,s risk of early death, according to a new study ... Association in Chicago. The report was also published online Nov. ... from more than a dozen clinical trials revealed no increase ...
(Date:11/18/2014)... 17, 2014 (HealthDay News) -- Until recently, insect-transmitted Chagas disease ... it has made its way to the United States over ... is typically transmitted via the bite of the "kissing bug," ... now a new study suggests that common bedbugs might be ... acquire and transmit the parasite. Our next step is to ...
Breaking Medicine News(10 mins):Health News:Orange County Facial Plastic Surgeon, Dr. Kevin Sadati Observes a New Trend of Non-invasive Cosmetic Surgery Procedures Becoming Increasingly Popular This Fall 2Health News:Orange County Facial Plastic Surgeon, Dr. Kevin Sadati Observes a New Trend of Non-invasive Cosmetic Surgery Procedures Becoming Increasingly Popular This Fall 3Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 2Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 3Health News:Head Trauma in Abused Babies, Toddlers Can Have Lifelong Impact 4Health News:Daily Aspirin Fails to Help Older Hearts in Japanese Study 2Health News:Daily Aspirin Fails to Help Older Hearts in Japanese Study 3Health News:Long-Term Use of Aspirin Plus Blood Thinner Is Safe: Study 2Health News:Long-Term Use of Aspirin Plus Blood Thinner Is Safe: Study 3Health News:Bedbugs Could Be Potential New Source of Tropical Disease in U.S. 2Health News:Bedbugs Could Be Potential New Source of Tropical Disease in U.S. 3
... , , , DURHAM, ... announced that company chairman and CEO, Chris Stern, will present at an ... The presentation will be at the Zurich Airport Radisson Hotel and ... webcast but will be open to interested investors. , ...
... WESTFORD, Mass., Sept. 22 Cynosure, Inc. (Nasdaq: ... array of light-based aesthetic treatment systems, today announced that President and ... will present at the third annual Maxim Group Growth Conference in ... will be webcast live over the Internet beginning at 10:00 a.m. ...
... may have boosted seniors, sexually transmitted infection rates, researchers ... widowers who recently lost their wives are more likely ... who are still married, a new study has found. ... drugs like Viagra could boost the risk, noting the ...
... , , SEATTLE, Sept. 22 ... firms, announced today that it has opened a new office in ... offices, will continue to serve existing clients while expanding the range ... "Milliman,s wide range of talents and sixty-plus years of experience ...
... , , MOUNTAIN ... in devices for clot removal in ischemic stroke patients, today announced ... DAC catheters are a first-in-class family of devices used to provide ... and other neurovascular procedures. , , The ...
... , PITTSBURGH, Sept. 22 Cohera Medical, ... the ISO 13485:2003 International Standard for the Design, Development, ... certification allows Cohera Medical to proceed with the CE ... novel internal surgical adhesive, upon completion of development for ...
Cached Medicine News:Health News:Cynosure to Present at the Maxim Group Growth Conference 2Health News:Sex With New Partners Raises Widowers' Disease Risk 2Health News:Milliman Announces the Opening of a New Office in San Juan, Puerto Rico 2Health News:Concentric Medical Launches Full Family of DAC(TM) Neurovascular Catheters 2Health News:Cohera Medical Receives ISO 13485 Certification: Company Meets International Standards for Design, Development and Manufacturing of Medical Devices 2
(Date:11/18/2014)... ATLANTA , Nov. 18, 2014   Rio ... partnership with University of Texas Health Science Center ... Brownsville , has selected Wellcentive,s suite ... empower providers in a four-county area to partner with ... the health of their Medicaid and uninsured patient populations, ...
(Date:11/18/2014)... Calif. , Nov. 17, 2014   ... Products Inc. (OTC: GWPC) is a diversified company. ... and convenience of advanced technology and proven expertise ... fundamental business of health and wellness.  WholeHEALTH Products, ... hospitals, doctors, clinics and healthcare centers, and 8 ...
(Date:11/18/2014)... N.J. , Nov. 18, 2014  A new ... countries finds that a large majority of the general ... cancer (84%), a devastating disease that is responsible for ... prostate cancers combined 1,2,4 . The "Any One Any ... understanding about the widespread impact of lung cancer, but ...
Breaking Medicine Technology:Rio Grande Valley Health Information Exchange and University of Texas Health Science Center Select Wellcentive to Manage Health and Cost of Medicaid and Uninsured Populations 2Rio Grande Valley Health Information Exchange and University of Texas Health Science Center Select Wellcentive to Manage Health and Cost of Medicaid and Uninsured Populations 3Rio Grande Valley Health Information Exchange and University of Texas Health Science Center Select Wellcentive to Manage Health and Cost of Medicaid and Uninsured Populations 4WholeHEALTH Product Inc. to File FDA Emergency Use Approval (EUA) for PCR Rapid Ebola Test 2Global survey of more than 10,000 adults highlights misperceptions about lung cancer, a disease that kills 1.59 million people annually 2Global survey of more than 10,000 adults highlights misperceptions about lung cancer, a disease that kills 1.59 million people annually 3Global survey of more than 10,000 adults highlights misperceptions about lung cancer, a disease that kills 1.59 million people annually 4Global survey of more than 10,000 adults highlights misperceptions about lung cancer, a disease that kills 1.59 million people annually 5Global survey of more than 10,000 adults highlights misperceptions about lung cancer, a disease that kills 1.59 million people annually 6
... Pharmaceuticals announced today that it has filed its first ... Drug Administration (FDA).  The recently filed product has been ... seven years of market exclusivity. In addition, the FDA ... primarily due to the safety advantages it offers. Fast ...
... that a new market research report is available in its ... Latin America http://www.reportlinker.com/p0192647/The-Outlook-for-Medical-Devices-in-Latin-America.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Equipment_and_Supply ... Brazil Chile Colombia ... Peru Venezuela The ...
Cached Medicine Technology:Arbor Pharmaceuticals Announces Filing of First NDA 2The Outlook for Medical Devices in Latin America 2The Outlook for Medical Devices in Latin America 3The Outlook for Medical Devices in Latin America 4
... D.O.R.C. Intraocular Electromagnet offers a truly unique ... intraocular foreign bodies (IOFB). Other magnets are ... offers an intraocular electromagnet for use through ... surgical technique. The D.O.R.C. Intraocular Electromagnet offers ...
... The new SureSigns VS1 ... vital signs monitor that provides ... seconds. The VS1 is designed ... with features like large, bright, ...
... continuous monitoring, the M3 and M4 monitors ... neonatal patient care. M Series monitors are ... a basic set of non-invasive parameters and ... Multi-Measurement Server extensions offer Mainstream or Microstream® ...
Compact networked patient monitors for flexible care....
Medicine Products: